Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

November 30, 2022
BioUtah News
Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654

November 22, 2022
Policy News
Sen. Lee Introduces Bill to Increase Patient Access to Biosimilars

On November 17, Sen. Mike Lee (R-UT) introduced the “Biosimilar Red Tape Elimination Act” to increase patient access to biosimilars and reduce costs by easing switching studies required to allow a biosimilar to be substituted for a biologic. View a one-page summary HERE. Currently, pharmacists can substitute generics in lieu of their branded counterparts without […]

November 22, 2022
BioUtah News
NEW DIGITAL HEALTH INITIATIVE TO CREATE NEXT GENERATION OF MEDICAL APPS, GAMES, AND TECHNOLOGIES

The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE

November 21, 2022
BioUtah News
Teva Announces Appointment of Richard Francis as President and CEO

Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future

November 17, 2022
BioUtah News
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information

SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the launch of UroSuite, a comprehensive suite of genetic risk assessment tests that cover every stage of prostate cancer care. UroSuite includes Myriad’s Prolaris® Prostate Cancer Test, MyRisk™ Hereditary Cancer Test, […]

November 15, 2022
BioUtah News
CenExel Creates Clinical Sciences Business Unit

CenExel announces a new Clinical Sciencesbusiness unit and more.

November 12, 2022
BioUtah News
BioHive Summit Recap

On Thursday, November 10, 2022, the BioHIve gathered at the Salt Palace for the annual BioHive Summit presented by Mayer Brown. It was the first time in three years the industry had gathered in person. The pent up demand for in-person networking combined with quality programming resulted in record registration of over 700 participants. Governor […]

November 11, 2022
BioUtah News
Betty Iverson Retirement

Betty Iverson Retirement Announced

November 11, 2022
BioUtah News
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update

PolarityTE provided a business update and reported financial results for the quarterly period ended September 30, 2022.

November 9, 2022
BioUtah News
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company

PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash.

November 2, 2022
BioUtah News
Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland

Clene announced that it has entered into a securities purchase agreement with certain existing stockholders.

November 2, 2022
BioUtah News
Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial

The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks Survival signal consistent with prior results […]

November 2, 2022
BioUtah News
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test

$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.

November 2, 2022
BioUtah News
Myriad Genetics Reports Third Quarter Financial Results

Myriad Genetics announced financial results for its third quarter ended September 30, 2022 and provided an update on business performance.

November 1, 2022
BioUtah News
Renalytix Reports Full Year Fiscal 2022 Results

Renalytix announced its full year results for the twelve months ended 30 June 2022.

November 1, 2022
BioUtah News
Merit Medical Reports Results for Quarter Ended September 30, 2022

Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.

October 27, 2022
BioUtah News
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

October 25, 2022
BioUtah News
KidneyIntelX Medicare Update

Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims for KidneyIntelX testing for patients with Medicare coverage.

October 19, 2022
BioUtah News
15th Annual 2022 Women Tech Award Recipients

The Women’s Tech Council announced eight award recipients from its twenty one finalists.

October 19, 2022
BioUtah News
Geneial Receives $2.3M NIH Grant

Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.

October 19, 2022
BioUtah News
SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS

SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy (DOE) to develop, design and characterize 3D-printed alumina ceramic heat exchangers for heating, ventilation, and air conditioning systems (HVAC).

October 19, 2022
BioUtah News
NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE

SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop and test an antimicrobial trauma device.

October 19, 2022
BioUtah News
Brandy Isaacks Joins CenExel as Vice President of Project Management & Scientific Affairs

CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations

October 19, 2022
BioUtah News
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer

Foldax announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday.